These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37887237)

  • 1. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients.
    Campani S; Talamonti M; Dall'Ara L; Coloretti I; Gatto I; Biagioni E; Tosi M; Meschiari M; Tonelli R; Clini E; Cossarizza A; Guaraldi G; Mussini C; Sarti M; Trenti T; Girardis M;
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
    Galli F; Bindo F; Motos A; Fernández-Barat L; Barbeta E; Gabarrús A; Ceccato A; Bermejo-Martin JF; Ferrer R; Riera J; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Menéndez R; Gonzalez J; Misuraca S; Palomeque A; Amaya-Villar R; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Lopez Lago A; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego Curto E; García-Garmendia JL; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; Lopez Messa J; M Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Roche-Campo F; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Boado MV; Rodríguez A; Antonelli M; Blasi F; Barbé F; Torres A;
    Intensive Care Med; 2023 Aug; 49(8):934-945. PubMed ID: 37507573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
    Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
    J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of C-Reactive Protein and Procalcitonin in the Early Identification of ICU-Acquired Infections in Critically Ill COVID-19 Patients.
    Cidade JP; Coelho L; Póvoa P
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
    Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
    BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.
    Mazaheri T; Ranasinghe R; Al-Hasani W; Luxton J; Kearney J; Manning A; Dimitriadis GK; Mare T; Vincent RP
    PLoS One; 2022; 17(5):e0266652. PubMed ID: 35500008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
    Kooistra EJ; van Berkel M; van Kempen NF; van Latum CRM; Bruse N; Frenzel T; van den Berg MJW; Schouten JA; Kox M; Pickkers P
    Crit Care; 2021 Aug; 25(1):281. PubMed ID: 34353339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A composite score combining procalcitonin, C-reactive protein and temperature has a high positive predictive value for the diagnosis of intensive care-acquired infections.
    Robriquet L; Séjourné C; Kipnis E; D'Herbomez M; Fourrier F
    BMC Infect Dis; 2013 Apr; 13():159. PubMed ID: 23547830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of sepsis biomarkers and their kinetics in the prognosis of septic shock due to bacterial infections.
    Bahloul M; Bradii S; Turki M; Bouchaala K; Ben Hamida C; Chelly H; Ayedi F; Bouaziz M
    Anaesthesiol Intensive Ther; 2021; 53(4):312-318. PubMed ID: 35257563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of serum C-reactive protein and procalcitonin levels and their connection to outcomes in community-acquired sepsis].
    Marosi B; Kiss R; Lakatos B; Szabó BG
    Orv Hetil; 2022 Oct; 163(43):1713-1720. PubMed ID: 36273355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis.
    Alejandre C; Guitart C; Balaguer M; Torrús I; Bobillo-Perez S; Cambra FJ; Jordan I
    Eur J Pediatr; 2021 Mar; 180(3):833-842. PubMed ID: 32929531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Cholinesterase, C-reactive Protein, Interleukin 6, and Procalcitonin Levels as Predictors of Mortality in Patients in the Intensive Care Unit.
    Liu Q; Fan X; Cui W; Wang X; Zhang Z; Wang N; Qiao L
    Turk J Anaesthesiol Reanim; 2023 Oct; 51(5):408-413. PubMed ID: 37876167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
    Boussekey N; Leroy O; Georges H; Devos P; d'Escrivan T; Guery B
    Infection; 2005 Aug; 33(4):257-63. PubMed ID: 16091896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Biomarker-Guided Prediction of Bloodstream Infection in Critically Ill Patients: C-Reactive Protein, Procalcitonin, and Leukocytes.
    Hertz FB; Ahlström MG; Bestle MH; Hein L; Mohr T; Lundgren JD; Galle T; Andersen MH; Murray D; Lindhardt A; Itenov TS; Jensen JUS
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac467. PubMed ID: 36225739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of procalcitonin in intensive care unit delirium].
    Ye J; Wang J; Zheng F; Shao X; Wang S; Gao H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):662-666. PubMed ID: 30045794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study.
    Theodorou VP; Papaioannou VE; Tripsianis GA; Panopoulou MK; Christophoridis EK; Kouliatsis GA; Gioka TM; Maltezos ES; Ktenidou-Kartali SI; Pneumatikos IA
    BMC Infect Dis; 2012 Oct; 12():247. PubMed ID: 23043618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS.
    Richards O; Pallmann P; King C; Cheema Y; Killick C; Thomas-Jones E; Harris J; Bailey C; Szakmany T
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
    Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
    J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.